发明授权
US07932277B2 Peptide inhibitors of hepatitis C virus replication 失效
丙型肝炎病毒复制肽抑制剂

Peptide inhibitors of hepatitis C virus replication
摘要:
The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
公开/授权文献
信息查询
0/0